- $3.13bn
- $8.42bn
- $3.63bn
Annual income statement for Marex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 January 1st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 20-F | 6-K |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 852 | 1,175 | 2,352 | 2,895 | 3,630 |
| Cost of Revenue | |||||
| Gross Profit | 511 | 665 | 1,180 | 1,508 | 2,024 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 783 | 1,055 | 2,158 | 2,602 | 3,226 |
| Operating Profit | 68.6 | 120 | 195 | 293 | 404 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 69.9 | 122 | 197 | 296 | 412 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 56.5 | 98.2 | 141 | 218 | 308 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 56.5 | 98.2 | 141 | 218 | 308 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 56.5 | 91.6 | 128 | 205 | 294 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.798 | 1.09 | 1.97 | 2.81 | 4.07 |
| Dividends per Share |